Washington DC
New York
Toronto
Distribution: (800) 510 0384
Press ID  
  • Login
Belmont Star
No Result
View All Result
Wednesday, October 15, 2025
  • Business ☆ Finance
  • Culture ☆ Arts
  • Lifestyle ☆ Entertainment
  • Technology ☆ Science
  • Fintech ☆ Cybersecurity
  • Eco ☆ Conservation
  • Business ☆ Finance
  • Culture ☆ Arts
  • Lifestyle ☆ Entertainment
  • Technology ☆ Science
  • Fintech ☆ Cybersecurity
  • Eco ☆ Conservation
No Result
View All Result
Belmont Star
No Result
View All Result

Haemonetics Receives FDA Clearance For NexSys PCS® With Persona™ Technology

Craig Richer by Craig Richer
November 18, 2020
in Technology ☆ Science
A A
Haemonetics Receives FDA Clearance For NexSys PCS® With Persona™ Technology

Haemonetics’ NexSys PCS® with Persona™ technology customizes plasma collection based on an individual donor’s body composition.

Share on FacebookShare on Twitter

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NexSys PCS® system with Persona™ technology. The new, proprietary Persona technology is the latest innovation on the NexSys PCS system and it customizes plasma collection based on an individual donor’s body composition.

“The NexSys PCS system has transformed and improved the way our customers can collect plasma,” said Chris Simon, Haemonetics’ President and CEO. “Persona builds on that legacy by delivering meaningful innovation and reinforces our commitment to supporting the plasma industry.”

BelmontNewsroom

BP Defence Launches Bullet-Resistant Backpacks for Enhanced Student Safety

USU Partners With Aaron Newman for Groundbreaking Research on Spaceflight Adaptation

Beyond the White Coat: How Social Media Is Humanizing Holistic Healthcare

The 510(k) clearance was supported by clinical data from the IMPACT (IMproving PlasmA CollecTion) study, a multicenter, prospective, double-blinded, randomized controlled clinical trial involving 3,443 donors who underwent 23,137 plasma donations. The study was one of the largest clinical trials on the topic of plasmapheresis and it demonstrated that the NexSys PCS system with Persona technology was safe and effective. Using NexSys PCS with Persona technology, which incorporates a novel, personalized percent plasma nomogram, study results showed an average 8.2% increase in volume of plasma collected per donation across the study population when compared with NexSys PCS® with YES® technology. Additionally, the average number of repeat donations was not impacted and increasing plasma collection volume up to a maximum of 1,000 mL was well tolerated in eligible donors.

The amount of plasma a donor can donate is currently based on a variable calculation, also called a nomogram, which is solely correlated to an individual’s weight. The IMPACT study showed that, compared to the current industry standard nomogram, the Persona technology and nomogram customizes collection to an individual donor’s body mass index (BMI) and hematocrit to optimize each collection and yield a greater average volume of plasma collected per donation.

“Plasma is an essential component used to make life-saving and life-improving medicines for many conditions, and the current nomogram has been a safe and effective method for collecting plasma for decades,” said Dr. Jan Hartmann, Haemonetics’ Vice President, Medical Affairs, Clinical Development and Medical Safety. “Persona now sets a new paradigm by leveraging improved technology and taking a personalized approach to optimize plasma collection for each individual donor.”

“Octapharma strives to improve the health and lives of people worldwide and our participation in this randomized clinical trial reinforces our commitment to advancing science in plasma collection,” said Judy Smith, Executive Vice President and Chief Operating Officer at Octapharma Plasma, Inc., whose collection centers served as the IMPACT study trial sites. “We are excited about the prospect of using this new technology to help meet the rising demand for plasma-derived therapies.”

According to the Plasma Protein Therapeutics Association (PPTA), approximately 750,000 people across Europe and North America rely on plasma for life-saving therapies. Plasma-derived medicines are used to treat hundreds of conditions, like primary immunodeficiency, hemophilia and others, and it can take hundreds of plasma donations to treat a single patient.

The results of the IMPACT study will be presented at the AABB 2020 Virtual Annual Meeting in the Plenary Oral Abstract Session on October 4.

Craig Richer

Craig Richer

Newsroom Editor

Belmont Newsroom

BP Defence Launches Bullet-Resistant Backpacks for Enhanced Student Safety
Technology ☆ Science

BP Defence Launches Bullet-Resistant Backpacks for Enhanced Student Safety

October 9, 2025
USU Partners with Aaron Newman for Groundbreaking Research on Spaceflight Adaptation
Technology ☆ Science

USU Partners With Aaron Newman for Groundbreaking Research on Spaceflight Adaptation

October 2, 2025
Beyond the White Coat: How Social Media Is Humanizing Holistic Healthcare
Technology ☆ Science

Beyond the White Coat: How Social Media Is Humanizing Holistic Healthcare

September 2, 2025
  • Booz Demands His Due – A Gritty Look Inside ‘What About Booz?’

https://hudsonweekly.com/booz-demands-his-due-a-gritty-look-inside-what-about-booz/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #music #newmusic
  • The Architect of AI’s New Language: A Conversation With Boris Kriuk

https://hudsonweekly.com/the-architect-of-ais-new-language-a-conversation-with-boris-kriuk/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #ai #tech
  • Overflow Expands Tap-to-Give Feature With More Flexible NFC Engagement for Churches

https://marketsherald.com/overflow-expands-tap-to-give-feature-with-more-flexible-nfc-engagement-for-churches/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #church #donation
  • Sensi.AI Secures $45 Million Series C Funding to Drive Care Innovation for Seniors

https://lincolncitizen.com/sensi-ai-secures-45-million-series-c-funding-to-drive-care-innovation-for-seniors/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • AMC Health Appoints Alan Petrazzi as Executive VP of Government Division to Drive Telehealth Innovations

https://lincolncitizen.com/amc-health-appoints-alan-petrazzi-as-executive-vp-of-government-division-to-drive-telehealth-innovations/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #telehealth #health
  • CareChoice Wins Outstanding Growth Award for Excellence in Home Care Services

https://belmontstar.com/carechoice-wins-outstanding-growth-award-for-excellence-in-home-care-services/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • BP Defence Launches Bullet-Resistant Backpacks for Enhanced Student Safety

https://belmontstar.com/bp-defence-launches-bullet-resistant-backpacks-for-enhanced-student-safety/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #backback #bulletproof
  • NexCore Group Breaks Ground on Two Innovative Senior Living Communities in Denver and North Bethesda

https://fairmontpost.com/nexcore-group-breaks-ground-on-two-innovative-senior-living-communities-in-denver-and-north-bethesda/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost

© 2025 Belmont Star. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison Graph • Fairmont Post • The Hudson Weekly

Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Removals: pr@belmontstar.com. Phone: (718) 313-5252. M-F: 9AM-5PM. Privacy Policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Business ☆ Finance
  • Culture ☆ Arts
  • Lifestyle ☆ Entertainment
  • Technology ☆ Science
  • Fintech ☆ Cybersecurity
  • Eco ☆ Conservation

© 2025 Belmont Star.